Intriguingly, the heatmap revealed that ALOX5AP was positively correlated with an abundance of immune inhibitors in ovarian cancer, compared to other cancer types, suggesting that ALOX5AP may have a potential to serve as an immunotherapy target in SOC. This evidence concerns the gene ALOX5AP and ovarian carcinoma.